Publications by authors named "Xing-Yu Zhong"

This meta-analysis assessed oncolytic virus therapy's efficacy for intermediate-to-advanced solid tumors. We systematically searched PubMed, Cochrane Library, and Embase databases until March 6, 2025. Our review included 87 studies, involving 5,385 individuals, encompassing 75 clinical trials and 12 retrospective studies.

View Article and Find Full Text PDF

Background: Prostate cancer is a prevalent condition among older males, with radical prostatectomy being the standard treatment. However, this procedure can inevitably impact urinary and sexual functions. Irreversible electroporation represents an innovative therapeutic approach that employs high-voltage electrical pulses to selectively eradicate tumor cells, potentially preserving vital normal tissue.

View Article and Find Full Text PDF
Article Synopsis
  • PROTAC (Proteolysis Targeting Chimera) is a developing technology that focuses on degrading specific proteins related to diseases, showing promise in both lab and clinical settings but facing challenges.
  • Recent advances in targeted protein degradation (TPD) have introduced optimized strategies to address the limitations of conventional PROTACs, improving aspects like drug access, tissue selectivity, and control over the degradation process.
  • The review outlines the progress in PROTAC technology, highlights improvements and new concepts, and aims to offer insights for future innovations and applications in drug design.
View Article and Find Full Text PDF
Article Synopsis
  • Telemedicine uses communication technologies for remote healthcare, especially in urology, and has seen growth due to 5G technology and the COVID-19 pandemic.
  • A comprehensive bibliometric analysis was conducted, reviewing 1,357 articles from 97 countries, revealing a steady increase in research publications over the last two decades.
  • The study identifies key research areas such as telemonitoring effectiveness, teleconsultation cost-benefit analysis, and telesurgery exploration, providing insights for future research directions.
View Article and Find Full Text PDF

We aimed to investigate the genomic and tumor microenvironmental (TME) profiles in non-muscle invasive bladder cancer (NMIBC) and explore potential predictive markers for Bacillus Calmette-Guérin (BCG) treatment response in high-risk NMIBC patients (according to European Association of Urology (EAU) risk stratification). 40 patients with high-risk NMIBC (cTis-T1N0M0) who underwent en bloc resection followed by BCG instillation were retrospectively enrolled. Surgical samples were subjected to Next Generation Sequencing (NGS) and multiplex immunofluorescence (mIF) assay.

View Article and Find Full Text PDF

Given that microbiological analysis can be an alternative method that overcomes the shortcomings of traditional forensic technology, and skin samples may be the most common source of cases, the analysis of skin microbiome was investigated in this study. High-throughput sequencing targeting the V3-V4 region of 16S rRNA gene was performed to reveal the skin microbiome of healthy individuals in Guangdong Han. The bacterial diversity of the palm, navel, groin and plantar of the same individual was analyzed.

View Article and Find Full Text PDF

The emergence of resistance to prostate cancer (PCa) treatment, particularly to androgen deprivation therapy (ADT), has posed a significant challenge in the field of PCa management. Among the therapeutic options for PCa, radiotherapy, chemotherapy, and hormone therapy are commonly used modalities. However, these therapeutic approaches, while inducing apoptosis in tumor cells, may also trigger stress-induced premature senescence (SIPS).

View Article and Find Full Text PDF
Article Synopsis
  • Enhanced cellular therapy is a new treatment approach that aims to improve the effectiveness of adoptive cellular therapy (ACT) by directly modifying immune cells using drugs or biotechnology.
  • Key strategies include blocking immune checkpoints to overcome tumor resistance, genetically enhancing cytokines for better cell migration, and designing multi-antigen chimeric antigen receptors (CARs) for targeted tumor recognition.
  • The article outlines the mechanisms and clinical applications of enhanced cellular therapy, highlighting both safety measures like suicide genes and cutting-edge technologies like PROTAC to improve treatment outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • - The study focuses on Image-Guided Surgery (IGS) in prostate cancer (PCa), emphasizing its role in improving surgery by accurately defining tumor boundaries and preserving healthy tissue.
  • - Researchers analyzed 2,389 publications from 75 countries between 2013 and 2023, highlighting significant contributions from the U.S. and identifying key institutions and authors in the field.
  • - This bibliometric analysis is the first of its kind, using specialized software to provide insights into trends and future directions in IGS research for PCa, particularly around PSMA-PET/CT technologies.
View Article and Find Full Text PDF

Highlights: This meta-analysis and systematic review aim to analyze the association between BT and oncological outcomes of patients undergoing RC for bladder cancer, and tries to find out whether the timing of blood transfusion could also have an effect on this relationship. A total of 20 retrospective studies from online databases and other sources are identified and enrolled in this study. The results show that BT administration during RC operation or perioperative period is significantly associated with worse oncological outcomes including ACM, CSM and DR.

View Article and Find Full Text PDF

Background: Bladder cancer (BCa) is the most common malignancy of the urinary tract which can be divided into non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC), and their microbial differences are not fully understood. This study was conducted by performing 2bRAD sequencing for Microbiome (2bRAD-M) on NMIBC and MIBC tissue samples to investigate the microbiota differences between NMIBC and MIBC individuals.

Methods: A total of 22 patients with BCa, including 7 NMIBC and 15 MIBC, were recruited.

View Article and Find Full Text PDF

Background: Cereblon (CRBN) has emerged as a vital E3 ubiquitin ligase for Proteolysis-targeting chimera (PROTAC) design. However, few studies focus on the physiological mechanism of CRBN, and more studies are needed to explore the influence of CRBN on tumorigenesis. This pan-cancer analysis aims to explore the prognostic and immunologic roles of CRBN, and provide new insight for CRBN into cancer treatment and PROTAC design.

View Article and Find Full Text PDF

Introduction: With the shortage of bacillus Calmette-Guérin (BCG) vaccine, it is important to find an alternative to BCG instillation, which is the most commonly used adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC) patients after transurethral resection of bladder tumor treatment (TURBt) to delay tumor recurrence. Hyperthermia intravesical chemotherapy (HIVEC) with mitomycin C (MMC) is a potential treatment choice. We aim to compare HIVEC with BCG instillation for the preventive efficacy of bladder tumor recurrence and progression.

View Article and Find Full Text PDF

Background: T cell immunoglobulin and ITIM domain (TIGIT) is a widely concerned immune checkpoint, which plays an essential role in immunosuppression and immune evasion. However, the role of TIGIT in normal organ tissues and renal clear cell carcinoma is unclear. We aim to identify the critical role of TIGIT in renal clear cell carcinoma and find potential targeted TIGIT drugs.

View Article and Find Full Text PDF

Introduction: Renal cell carcinoma (RCC) is one of the most common urinary tumors. The risk of metastasis for patients with RCC is about 1/3, among which 30−40% have lymph node metastasis, and the existence of lymph node metastasis will greatly reduce the survival rate of patients. However, the necessity of lymph node dissection is still controversial at present.

View Article and Find Full Text PDF

Background: With the growth and aging of population, the incidence of prostate cancer will increase year by year, which is bound to bring greater economic burden to the society. There has been greater interest in the anticancer effects of statin in recent years. It is controversial whether statin use is associated with the risk of prostate cancer (PCa).

View Article and Find Full Text PDF

Objective: Although the prognostic effect of statins on patients with prostate cancer (PCa) has been frequently evaluated, a consistent result is still lacking. We aimed to evaluate the association between statin use and mortality among patients with PCa after definite therapies.

Methods: A systematic search of PubMed and other databases for cohort studies about the effect of statins on patients with PCa was performed until April 2022.

View Article and Find Full Text PDF

Introduction: Bladder cancer (BCa) is the 10th most common type of cancer worldwide, and human papillomavirus (HPV) is the most common sexually transmitted infection. However, the relationship between HPV infection and the risk of BCa is still controversial and inconclusive.

Methods: This systematic review and meta-analysis were conducted following the PRISMA 2020 reporting guideline.

View Article and Find Full Text PDF

Bladder cancer (BCa) is the 10th most commonly diagnosed cancer worldwide, and cellular senescence is defined as a state of permanent cell cycle arrest and considered to play important roles in the development and progression of tumor. However, the comprehensive effect of senescence in BCa has not ever been systematically evaluated. Using the genome-wide CRISPR screening data acquired from DepMap (Cancer Dependency Map), senescence genes from the CellAge database, and gene expression data from The Cancer Genome Atlas (TCGA), we screened out 12 senescence genes which might play critical roles in BCa.

View Article and Find Full Text PDF

Background: Numerous studies have reported the role of statins on biochemical recurrence (BCR) among patients with prostate cancer (PCa) after definite treatment. However, the conclusions of these studies are contradictory. We aimed to determine the effect of statins on BCR of PCa using a systematic review and meta-analysis.

View Article and Find Full Text PDF

Increased aerobic glycolysis is a hallmark of cancer metabolism. How cancer cells coordinate glucose metabolism with extracellular glucose levels remains largely unknown. Here, we report that coactivator-associated arginine methyltransferase 1 (CARM1 or PRMT4) signals glucose availability to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and suppresses glycolysis in liver cancer cells.

View Article and Find Full Text PDF